Alzheimer's Disease as a Membrane Dysfunction Tauopathy? New Insights into the Amyloid Cascade Hypothesis

被引:0
|
作者
Olejar, Tomas [1 ,2 ,3 ,4 ]
Jankovska, Nikol [1 ,2 ,3 ,4 ]
Matej, Radoslav [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Charles Univ Prague, Thomayer Univ Hosp, Fac Med 3, Dept Pathol & Mol Med, Prague 14000, Czech Republic
[2] Thomayer Fac Hosp, Prague 14059, Czech Republic
[3] Charles Univ Prague, Fac Med 3, Dept Pathol, Prague 10034, Czech Republic
[4] Univ Hosp Kralovske Vinohrady, Prague 10034, Czech Republic
[5] Charles Univ Prague, Fac Med 1, Dept Pathol, Prague 12800, Czech Republic
[6] Gen Univ Hosp, Prague 12800, Czech Republic
关键词
Alzheimer's disease; tauopathy; amyloid beta; membrane dysfunction; BETA-PROTEIN; APOLIPOPROTEIN-E; A-BETA; NEURODEGENERATION; PATHOGENESIS; CLEARANCE; OLIGOMERS; PLAQUES; MODEL; TAU;
D O I
10.3390/ijms25179689
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid cascade hypothesis postulates that extracellular deposits of amyloid beta (A beta) are the primary and initial cause leading to the full development of Alzheimer's disease (AD) with intracellular neurofibrillary tangles; however, the details of this mechanism have not been fully described until now. Our preliminary data, coming from our day-to-day neuropathology practice, show that the primary location of the hyperphosphorylated tau protein is in the vicinity of the cell membrane of dystrophic neurites. This observation inspired us to formulate a hypothesis that presumes an interaction between low-density lipoprotein receptor-related protein 1 (LRP1) and fibrillar aggregates of, particularly, A beta(42) anchored at the periphery of neuritic plaques, making internalization of the LRP1-A beta(42) complex infeasible and, thus, causing membrane dysfunction, leading to the tauopathy characterized by intracellular accumulation and hyperphosphorylation of the tau protein. Understanding AD as a membrane dysfunction tauopathy may draw attention to new treatment approaches not only targeting A beta(42) production but also, perhaps paradoxically, preventing the formation of LRP1-A beta(42).
引用
收藏
页数:9
相关论文
共 50 条
  • [41] From the amyloid hypothesis to the autoimmune hypothesis of Alzheimer's disease
    Lim, Bryant
    Prassas, Ioannis
    Diamandis, Eleftherios P.
    DIAGNOSIS, 2022, 9 (02) : 280 - 281
  • [42] The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
    Patrick L. McGeer
    Edith G. McGeer
    Acta Neuropathologica, 2013, 126 : 479 - 497
  • [43] The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
    McGeer, Patrick L.
    McGeer, Edith G.
    ACTA NEUROPATHOLOGICA, 2013, 126 (04) : 479 - 497
  • [44] An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis
    Caselli, Richard J.
    Knopman, David S.
    Bu, Guojun
    ALZHEIMERS & DEMENTIA, 2020, 16 (11) : 1582 - 1590
  • [45] Truncating the amyloid cascade hypothesis:: the role of C-terminal Aβ peptides in Alzheimer's disease
    Teplow, DB
    NEUROBIOLOGY OF AGING, 1999, 20 (01) : 71 - 73
  • [46] Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis
    Mondragon-Rodriguez, Siddhartha
    Salgado-Burgos, Humberto
    Pena-Ortega, Fernando
    NEURAL PLASTICITY, 2020, 2020
  • [47] The capillary dysfunction hypothesis of Alzheimer's disease
    Ostergaard, Leif
    Aamand, Rasmus
    Gutierrez-Jimenez, Eugenio
    Ho, Yi-Ching L.
    Blicher, Jakob U.
    Madsen, Soren M.
    Nagenthiraja, Kartheeban
    Dalby, Rikke B.
    Drasbek, Kim R.
    Moller, Arne
    Braendgaard, Hans
    Mouridsen, Kim
    Jespersen, Sune N.
    Jensen, Morten S.
    West, Mark J.
    NEUROBIOLOGY OF AGING, 2013, 34 (04) : 1018 - 1031
  • [48] The Alzheimer's disease mitochondrial cascade hypothesis: An update
    Swerdlow, Russell H.
    Khan, Shaharyar M.
    EXPERIMENTAL NEUROLOGY, 2009, 218 (02) : 308 - 315
  • [49] Challenging the amyloid cascade hypothesis -: Senile plaques and amyloid-β as protective adaptations to Alzheimer disease
    Lee, HG
    Casadesus, G
    Zhu, XW
    Takeda, A
    Perry, G
    Smith, MA
    STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF AGING MAY BE FORESEEABLE, 2004, 1019 : 1 - 4
  • [50] Aβ as a bioflocculant:: implications for the amyloid hypothesis of Alzheimer's disease
    Robinson, SR
    Bishop, GM
    NEUROBIOLOGY OF AGING, 2002, 23 (06) : 1051 - 1072